Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Feb;63(2):294–298. doi: 10.1172/JCI109302

Effect of Atropine on Vagal Release of Gastrin and Pancreatic Polypeptide

Mark Feldman 1,2,3, Charles T Richardson 1,2,3, Ian L Taylor 1,2,3, John H Walsh 1,2,3
PMCID: PMC371952  PMID: 429555

Abstract

We studied the effect of several doses of atropine on the serum gastrin and pancreatic polypeptide responses to vagal stimulation in healthy human subjects. Vagal stimulation was induced by sham feeding. To eliminate the effect of gastric acidity on gastrin release, gastric pH was held constant (pH 5) and acid secretion was measured by intragastric titration. Although a small dose of atropine (2.3 μg/kg) significantly inhibited the acid secretory response and completely abolished the pancreatic polypeptide response to sham feeding, this dose of atropine significantly enhanced the gastrin response. Higher atropine doses (7.0 and 21.0 μg/kg) had effects on gastrin and pancreatic polypeptide release which were similar to the 2.3-μg/kg dose. Atropine (0.78 and 2.3 μg/kg) without sham feeding significantly inhibited basal acid secretion and also led to significant increases in serum gastrin above basal levels. The gastrin response to sham feeding with 2.3 μg/kg atropine was significantly greater than the sum of the gastrin responses to sham feeding alone and to 2.3 μg/kg atropine alone, indicating potentiation of vagal gastrin release by atropine. We conclude: (a) Unlike vagally mediated gastric acid secretion and pancreatic polypeptide release which can be blocked by atropine, vagal gastrin release is potentiated by atropine. This observation suggests the existence of a vagal-cholinergic pathway which normally (i.e., in the absence of atropine) inhibits gastrin release. (b) Because atropine (without sham feeding) increased basal gastrin levels, it is likely that the cholinergic pathway which inhibits gastrin release is active even when the vagus nerve is not stimulated by sham feeding.

Full text

PDF
294

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker H. D., Reeder D. D., Thompson J. C. Effect of atropine on basal and food-stimulated serum gastrin levels in man. Surgery. 1974 May;75(5):701–704. [PubMed] [Google Scholar]
  2. Christensen K. C., Stadil F. On the beta-adrenergic contribution to the gastric acid and gastrin responses to hypoglycaemia in man. Scand J Gastroenterol Suppl. 1976;37:81–86. [PubMed] [Google Scholar]
  3. Dockray G. J., Walsh J. H. Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients. Gastroenterology. 1975 Feb;68(2):222–230. [PubMed] [Google Scholar]
  4. Farooq O., Walsh J. H. Atropine enhances serum gastrin response to insulin in man. Gastroenterology. 1975 Apr;68(4 Pt 1):662–666. [PubMed] [Google Scholar]
  5. Feldman M., Walsh J. H., Wong H. C., Richardson C. T. Role of gastrin heptadecapeptide in the acid secretory response to amino acids in man. J Clin Invest. 1978 Feb;61(2):308–313. doi: 10.1172/JCI108940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fordtran J. S., Walsh J. H. Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest. 1973 Mar;52(3):645–657. doi: 10.1172/JCI107226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ganguli P. C., Hunter W. M. Radio-immunoassay of gastrin in human plasma. J Physiol. 1972 Jan;220(2):499–510. [PMC free article] [PubMed] [Google Scholar]
  8. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  9. Higgs R. H., Humphries T. J., Castell D. O., McGuigan J. E. Lower esophageal sphincter pressures and serum gastrin levels after cholinergic stimulation. Am J Physiol. 1976 Oct;231(4):1250–1253. doi: 10.1152/ajplegacy.1976.231.4.1250. [DOI] [PubMed] [Google Scholar]
  10. Jaffe B. M., Clendinnen B. G., Clarke R. J., Williams J. A. Effect of selective and proximal gastric vagotomy on serum gastrin. Gastroenterology. 1974 May;66(5):944–953. [PubMed] [Google Scholar]
  11. Korman M. G., Soveny C., Hansky J. Serum gastrin in duodenal ulcer. I. Basal levels and effect of food and atropine. Gut. 1971 Nov;12(11):899–902. doi: 10.1136/gut.12.11.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kottmeier C. A., Gravenstein J. S. The parasympathomimetic activity of atropine and atropine methylbromide. Anesthesiology. 1968 Nov-Dec;29(6):1125–1133. doi: 10.1097/00000542-196811000-00008. [DOI] [PubMed] [Google Scholar]
  13. Kronborg O., Stadil J., Rehfeld J., Christiansen P. M. Relationship between serum gastrin concentrations and gastric acid secretion in duodenal ulcer patients before and after selective and highly selective vagotomy. Scand J Gastroenterol. 1973;8(6):491–496. [PubMed] [Google Scholar]
  14. McCallum R. W., Kline M. M., Curry N., Sturdevant R. A. Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients. Gastroenterology. 1975 May;68(5 Pt 1):1114–1118. [PubMed] [Google Scholar]
  15. McGuigan J. E., Trudeau W. L. Serum gastrin levels before and after vagotomy and pyloroplasty or vagotomy and antrectomy. N Engl J Med. 1972 Jan 27;286(4):184–188. doi: 10.1056/NEJM197201272860404. [DOI] [PubMed] [Google Scholar]
  16. Richardson C. T., Walsh J. H., Cooper K. A., Feldman M., Fordtran J. S. Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest. 1977 Aug;60(2):435–441. doi: 10.1172/JCI108793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richardson C. T., Walsh J. H., Hicks M. I., Fordtran J. S. Studies on the mechanisms of food-stimulated gastric acid secretion in normal human subjects. J Clin Invest. 1976 Sep;58(3):623–631. doi: 10.1172/JCI108509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schrumpf E., Myren J. Effect of atropine on plasma concentration of gastrin in fasting subjects. Scand J Gastroenterol. 1974;9(2):123–125. [PubMed] [Google Scholar]
  19. Schwartz T. W., Holst J. J., Fahrenkrug J., Jensen S. L., Nielsen O. V., Rehfeld J. F., de Muckadell O. B., Stadil F. Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest. 1978 Mar;61(3):781–789. doi: 10.1172/JCI108992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stadil F. Effect of vagotomy on gastrin release during insulin hypoglycaemia in ulcer patients. Scand J Gastroenterol. 1972;7(3):225–231. doi: 10.3109/00365527209181157. [DOI] [PubMed] [Google Scholar]
  21. Stadil F., Rehfeld J. F. Gastrin response to insulin after selective, highly selective, and truncal vagotomy. Gastroenterology. 1974 Jan;66(1):7–15. [PubMed] [Google Scholar]
  22. Vatn M. H., Schrumpf E., Myren J. The effect of carbachol and pentagastrin on the gastric secretion of acid pepsin, and intrinsic factor (IF) in man. Scand J Gastroenterol. 1975;10(1):55–58. [PubMed] [Google Scholar]
  23. Walsh J. H., Yalow R. S., Berson S. A. The effect of atropine on plasma gastrin response to feeding. Gastroenterology. 1971 Jan;60(1):16–21. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES